A detailed history of Susquehanna Fundamental Investments, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 1,325,937 shares of PFE stock, worth $35 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
1,325,937
Previous 1,467,107 9.62%
Holding current value
$35 Million
Previous $40.7 Billion 8.87%
% of portfolio
0.86%
Previous 1.9%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$25.26 - $29.6 $3.57 Million - $4.18 Million
-141,170 Reduced 9.62%
1,325,937 $37.1 Billion
Q1 2024

May 07, 2024

BUY
$25.89 - $29.73 $38 Million - $43.6 Million
1,467,107 New
1,467,107 $40.7 Billion
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $1.3 Million - $1.58 Million
-29,620 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $17.5 Million - $21.6 Million
-381,800 Reduced 92.8%
29,620 $1.53 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $298,300 - $383,192
-7,600 Reduced 1.81%
411,420 $17.7 Million
Q2 2021

Aug 11, 2021

SELL
$35.91 - $40.68 $8.35 Million - $9.45 Million
-232,390 Reduced 35.67%
419,020 $16.4 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $3.89 Million - $4.38 Million
116,075 Added 21.68%
651,410 $23.6 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $3.84 Million - $4.88 Million
114,586 Added 27.23%
535,335 $19.7 Million
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $4.96 Million - $5.82 Million
156,349 Added 59.13%
420,749 $15.4 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $7.96 Million - $9.66 Million
264,400 New
264,400 $8.65 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.